Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Webistes |
     
  4. Contact Us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

About us

Contact us

Sanofi House,
CTS No.117-B, L&T Business Park,
Saki Vihar Road, Powai,
Mumbai 400072

Tel no. (022) 28032000
Fax no.(022) 28032846

For redressal of investor grievances,

please write to

Registrar & Share Transfer Agent
Link Intime India Pvt. Ltd
C 10, 247 Park, L B S Marg,
Vikhroli West, Mumbai 400083.
Email: rnt.helpdesk@linkintime.co.in
Tel.: (91 22) 49186270
Fax: (91 22) 49186060

Company Secretary & Compliance Officer
Mr. Girish Tekchandani

Sanofi India Limited
E-Mail ID: igrc.sil@sanofi.com
Tel.: (91-22) 28032000
Fax: (91-22) 28032846

Content :

A world-class pharmaceutical manufacturer

Sanofi India Limited was incorporated in May 1956 under the name Hoechst Fedco Pharma Private Limited. Over the years, its name was changed to Hoechst Pharmaceuticals Private Limited, Hoechst India Limited, Hoechst Marion Roussel Limited and Aventis Pharma Limited.

 

Sanofi, one of the world's leading pharmaceutical companies, and its 100% subsidiary, Hoechst GmbH, are the major shareholders of Sanofi India Limited and together hold 60.4% of its paid-up share capital.

The shares of Sanofi India Limited are quoted on the Bombay Stock Exchange (Security Code: 500674) and the National Stock Exchange (Security Code: Sanofi).

SANOFI INDIA LIMITED

Updated April 21, 2016

Module :

Corporate information

Corporate information

 

Medical Information / Pharmacovigilance

All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters/medical emergencies.

Pharmacovigilance remains a key activity in the assessment of the therapeutic value of products. Sanofi ensures continuous monitoring and management of the safety profile of all its products through its drug safety data collection worldwide.
For reporting adverse events, please send an email to PV.india@sanofi.com

A key activity of Sanofi is to provide updated medical information in compliance with Indian regulations, on its products, to healthcare professionals.
For medical information, please send your queries to medinfo.india@sanofi.com

You can also call us between 9AM and 5PM on any working day* at 022-28032000. Please select IVRS option 2 for medical information and IVRS option 3 for reporting adverse events.

*Please note that we are closed on Saturday, Sunday and Public Holidays.